PureCycle Technologies Future Growth
Future criteria checks 5/6
PureCycle Technologies is forecast to grow earnings and revenue by 53.8% and 50% per annum respectively while EPS is expected to grow by 39% per annum.
Key information
53.8%
Earnings growth rate
39.0%
EPS growth rate
Chemicals earnings growth | 17.3% |
Revenue growth rate | 50.0% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 25 Jun 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 250 | -48 | -112 | -2 | 3 |
12/31/2025 | 126 | -70 | -336 | -53 | 4 |
12/31/2024 | 36 | -164 | -164 | -130 | 2 |
3/31/2024 | N/A | -161 | -241 | -119 | N/A |
12/31/2023 | N/A | -102 | -249 | -95 | N/A |
9/30/2023 | N/A | -87 | -294 | -77 | N/A |
6/30/2023 | N/A | -127 | -355 | -71 | N/A |
3/31/2023 | N/A | -85 | -345 | -63 | N/A |
12/31/2022 | N/A | -85 | -353 | -65 | N/A |
9/30/2022 | N/A | -95 | -324 | -63 | N/A |
6/30/2022 | N/A | -81 | -269 | -55 | N/A |
3/31/2022 | N/A | -77 | -207 | -51 | N/A |
12/31/2021 | N/A | -78 | -192 | -55 | N/A |
9/30/2021 | N/A | -94 | -165 | -49 | N/A |
6/30/2021 | N/A | -81 | -124 | -45 | N/A |
3/31/2021 | N/A | -75 | -97 | -34 | N/A |
12/31/2020 | N/A | -56 | -48 | -18 | N/A |
9/30/2020 | N/A | -24 | -15 | -9 | N/A |
12/31/2019 | N/A | -22 | -12 | -6 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PCT is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.4%).
Earnings vs Market: PCT is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: PCT is expected to become profitable in the next 3 years.
Revenue vs Market: PCT's revenue (50% per year) is forecast to grow faster than the US market (8.7% per year).
High Growth Revenue: PCT's revenue (50% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PCT's Return on Equity is forecast to be high in 3 years time